查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2160823

2034年睡眠呼吸中止症和呼吸治療設備市場預測—按設備類型、應用、最終用戶和地區分類的全球分析

Sleep Apnea & Respiratory Therapy Devices Market Forecasts to 2034 - Global Analysis By Device Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球睡眠呼吸中止症和呼吸治療設備市場規模將達到 292 億美元，並在預測期內以 7.2% 的複合年成長率成長，到 2034 年將達到 509 億美元。

睡眠呼吸中止症和呼吸治療設備是專門用於治療睡眠相關呼吸障礙和呼吸問題的專業醫療技術。主要解決方案包括持續性正壓呼吸器（CPAP）和雙水平氣道正壓通氣（BiPAP）系統、自適應伺服呼吸器、氧氣濃縮機和其他呼吸支援設備。這些技術有助於維持充足的氣流、穩定氣道、最大限度地減少呼吸中斷，並在睡眠期間進行有效的呼吸系統護理。持續的創新致力於研發更小巧、更安靜的設備，提高患者的舒適度，增強數位化連接性，實現遠端監測功能，並採用個人化的治療方案，從而提高治療依從性和整體療效。

根據美國睡眠醫學會 (AASM) 的數據，美國約有 3,000 萬名成年人患有阻塞型睡眠呼吸中止症症 (OSA)，這凸顯了需要診斷和呼吸治療的患者數量龐大。

睡眠呼吸中止症盛行率上升

睡眠呼吸中止症盛行率的上升顯著推動了睡眠呼吸中止症及呼吸治療設備的市場成長。肥胖率上升、人口老化、久坐的生活方式以及糖尿病和心血管疾病等相關疾病，都使人們更容易患上睡眠呼吸障礙。臨床醫生和患者對該疾病的意識提升，促使更多人尋求篩檢和適當的治療。因此，確診病例數量不斷增加，帶動了對持續性正壓呼吸器（CPAP）、雙水平氣道正壓通氣（BiPAP）和其他呼吸支援技術的需求，並推動了這些技術在醫院、診所和居家照護機構中的應用。

先進呼吸治療設備高成本

昂貴的呼吸治療設備仍然是市場擴張的潛在障礙。先進的持續性正壓呼吸器（CPAP）、雙水平氣道正壓通氣（BiPAP）、自適應伺服通氣（ASV）和數位化連接系統都需要大量的購置成本，這對保險覆蓋範圍有限的患者來說是一個挑戰。此外，由於需要反覆更換面罩、配件、設備維護、更換零件以及進行臨床後續觀察，治療費用也會增加。這些經濟負擔可能會阻礙消費者和醫療系統（尤其是那些專注於成本的機構）開始或繼續治療。因此，經濟方面的考慮可能會阻礙先進呼吸治療技術的進一步普及。

攜帶式和家用設備的擴展

對便利的居家照護和攜帶式呼吸設備日益成長的需求帶來了巨大的市場機會。患者越來越重視能夠減少就醫次數、不影響日常生活的治療方案。小型CPAP和BiPAP設備、攜帶式設計、電池供電系統以及直覺的操控方式，使得居家或旅行時的治療管理更加便利。製造商可以透過開發更安靜、更輕、更人性化的產品來滿足這些需求。隨著居家照護的普及，治療的可近性也將隨之提高，從而在成熟和新興的醫療保健市場中創造商機。

激烈的競爭與產品價格壓力

激烈的競爭和不斷上漲的價格壓力會給參與企業帶來障礙。老牌醫療設備製造商面臨來自新興製造商的競爭，這些新興製造商提供價格較低的CPAP、BiPAP和呼吸治療產品。注重預算的患者和醫療保健機構往往更傾向於經濟實惠的替代方案，這可能迫使製造商在不犧牲產品品質或性能的前提下降低價格。同時，日益激烈的競爭也要求企業不斷創新，並增加對產品研發、促銷和客戶服務的投入。因此，企業在努力保持競爭力並實現長期成長的同時，可能會面臨利潤率下降的壓力。

新型冠狀病毒（COVID-19）的影響：

新冠疫情透過診斷程序延誤、睡眠診所就診受限以及整個醫療供應鏈中斷等方式，對睡眠呼吸中止症和呼吸治療設備市場造成了衝擊。在醫療服務中斷期間，非緊急檢查和治療經常被推遲。另一方面，人們對呼吸健康的日益關注也推動了對特定呼吸支援和監測技術的需求。疫情也促進了遠端醫療和居家照護的發展，使其成為面對面就診的替代方案。因此，遠端患者監護、連網型設備和居家照護解決方案在呼吸治療管理中發揮越來越重要的作用。

在預測期內，睡眠呼吸系統護理領域預計將佔據最大的市場佔有率。

預計在預測期內，睡眠呼吸系統護理領域將佔據最大的市場佔有率。此領域涵蓋旨在識別、控制和治療睡眠相關呼吸障礙的技術。主要解決方案包括持續性正壓呼吸器（CPAP）、雙水平氣道正壓通氣（BiPAP）、自適應伺服通氣（ASV）、氧氣療法以及配套的監測系統。人們對睡眠呼吸中止症的認知不斷提高，以及對有效呼吸支持的日益重視，都提升了該領域的重要性。專注於提升使用者舒適度、易用性、連結性和個人化治療的創新，進一步促進了睡眠呼吸障礙治療的普及和持續管理。

預計在預測期內，居家照護環境區隔市場將呈現最高的複合年成長率。

在預測期內，居家照護產業預計將呈現最高的成長率。對便利且靈活的治療方案日益成長的需求，促使患者在傳統醫療機構之外接受呼吸治療。攜帶式CPAP和BiPAP系統、互聯技術、遠端監測功能以及更簡化的設備設計，都為此轉變提供了支援。遠端醫療和虛擬病患管理的日益普及也促進了居家照護的發展。這些進步共同推動了呼吸治療設備的普及、治療連續性的提高以及廣泛應用。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其較高的疾病認知度、完善的睡眠護理基礎設施以及呼吸治療技術的廣泛應用。 CPAP、BiPAP 和其他正壓通氣（CPAP）解決方案在全部區域被廣泛用於治療睡眠呼吸中止症。診斷率的提高和醫療保健服務的進步正在推動市場需求。美國預計將繼續保持主要貢獻者的地位，這得益於其龐大的睡眠呼吸中止症患者群體、完善的臨床能力和成熟的醫療保健生態系統。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。人們對睡眠呼吸障礙的認知不斷提高、醫療基礎設施的完善、診斷服務的改進以及呼吸治療服務的普及，正在推動市場擴張。不斷成長的醫療支出和該地區龐大的患者群體，為醫療設備的普及應用提供了有利條件。居家治療、遠端醫療解決方案和先進呼吸技術的日益普及，進一步刺激了市場需求。開發中國家持續加大醫療投入，也為區域市場成長創造了更多機會。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球睡眠呼吸中止症與呼吸治療設備市場：依設備類型分類

  • 正壓通氣（PAP）設備
    • 持續性呼吸道正壓通氣（CPAP）設備
    • 雙水平氣道正壓通氣設備
    • APAP設備
  • 氧氣療法設備
    • 氧氣濃縮機
    • 氧氣罐
  • 人工呼吸器
  • 噴霧器
  • 加濕器
  • 配件和耗材
    • 面具
    • 管道
    • 篩選

第6章 全球睡眠呼吸中止症與呼吸治療設備市場：依應用分類

  • 睡眠呼吸中止症的管理
  • 慢性阻塞性肺病（COPD）
  • 氣喘
  • 其他呼吸系統疾病

第7章 全球睡眠呼吸中止症與呼吸治療設備市場：依最終使用者分類

  • 醫院
  • 門診手術中心（ASC）
  • 診所
  • 居家醫療

第8章 全球睡眠呼吸中止症和呼吸治療設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第9章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第10章：產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第11章：公司簡介

  • ResMed Inc.
  • Koninklijke Philips NV
  • Fisher & Paykel Healthcare Limited
  • Drive DeVilbiss Healthcare
  • Lowenstein Medical SE & Co. KG
  • BMC Medical Co., Ltd.
  • Inspire Medical Systems, Inc.
  • Compumedics Limited
  • SomnoMed Ltd.
  • Nihon Kohden Corporation
  • Natus Medical Incorporated
  • Breas Medical AB
  • SEFAM
  • React Health
  • Wellell Inc.
  • ZOLL Medical Corporation
  • Medtronic plc
  • Cadwell Industries Inc.
Product Code: SMRC40187

According to Stratistics MRC, the Global Sleep Apnea & Respiratory Therapy Devices Market is accounted for $29.2 billion in 2026 and is expected to reach $50.9 billion by 2034 growing at a CAGR of 7.2% during the forecast period. Sleep Apnea & Respiratory Therapy Devices comprise specialized medical technologies used to address sleep-related breathing abnormalities and respiratory challenges. Key solutions include CPAP and BiPAP systems, adaptive servo-ventilation equipment, oxygen concentrators, and other respiratory support devices. These technologies help sustain adequate airflow, stabilize airways, minimize breathing interruptions, and promote effective respiratory management during sleep. Ongoing innovation is centered on smaller and quieter devices, improved patient comfort, digital connectivity, remote monitoring capabilities, and individualized treatment approaches, supporting better therapy adherence and overall treatment effectiveness.

According to the American Academy of Sleep Medicine (AASM), nearly 30 million adults in the United States have obstructive sleep apnea (OSA), highlighting a substantial patient base requiring diagnosis and respiratory therapy.

Market Dynamics:

Driver:

Rising prevalence of sleep apnea

Growing incidence of sleep apnea is significantly supporting the Sleep Apnea & Respiratory Therapy Devices Market. Factors including rising obesity rates, population aging, inactive lifestyles, and related diseases such as diabetes and cardiovascular conditions are increasing susceptibility to breathing disturbances during sleep. Improved awareness among clinicians and patients is encouraging more people to seek screening and appropriate treatment. The expanding number of diagnosed cases is consequently increasing demand for CPAP, BiPAP, and other respiratory support technologies, strengthening adoption across hospitals, clinics, and homecare environments.

Restraint:

High cost of advanced respiratory therapy devices

Expensive respiratory therapy equipment remains a potential barrier to market expansion. Advanced CPAP, BiPAP, adaptive servo-ventilation, and digitally connected systems can involve significant purchasing costs, creating challenges for patients with limited insurance support. Treatment expenses may also increase through recurring requirements for masks, accessories, device servicing, replacement parts, and clinical follow-up. Such financial pressures can reduce willingness to begin or maintain therapy, particularly among cost-conscious consumers and healthcare systems. Consequently, affordability concerns may restrict wider penetration of sophisticated respiratory treatment technologies.

Opportunity:

Expansion of portable and home-based devices

Growing demand for convenient homecare and portable respiratory equipment provides substantial opportunities for market development. Patients increasingly value treatment solutions that accommodate everyday activities while minimizing frequent healthcare facility visits. Smaller CPAP and BiPAP devices, portable designs, battery-operated systems, and intuitive controls can make therapy easier to manage at home or while traveling. Manufacturers can respond by creating quieter, lighter, and more user-friendly products. Broader adoption of home-based care can expand access to therapy and support commercial opportunities across both established and developing healthcare markets.

Threat:

Intense competition and product price pressure

Strong competitive intensity and increasing pricing pressure may create obstacles for market participants. Established device companies face competition from newer manufacturers that provide lower-priced CPAP, BiPAP, and respiratory therapy products. Budget-conscious patients and healthcare organizations can favor economical alternatives, encouraging manufacturers to control prices without compromising device quality or performance. At the same time, competition requires continuous innovation and greater investment in product development, promotion, and customer services. Consequently, companies may experience tighter margins while attempting to maintain competitiveness and long-term growth.

Covid-19 Impact:

The COVID-19 pandemic influenced the Sleep Apnea & Respiratory Therapy Devices Market through postponed diagnostic procedures, restricted sleep-clinic access, and interruptions across medical supply chains. Non-urgent evaluations and treatments were frequently delayed during periods of healthcare disruption. At the same time, greater concern surrounding respiratory health supported demand for selected respiratory support and monitoring technologies. The pandemic also encouraged telehealth and home-based treatment as alternatives to physical appointments. Consequently, remote patient monitoring, connected devices, and homecare solutions gained greater importance in respiratory therapy management.

The sleep apnea management segment is expected to be the largest during the forecast period

The sleep apnea management segment is expected to account for the largest market share during the forecast period. It includes technologies designed to identify, control, and treat sleep-related breathing disturbances. Major solutions encompass CPAP, BiPAP, adaptive servo-ventilation, oxygen-based therapy, and supporting monitoring systems. Increasing recognition of sleep apnea and greater emphasis on effective respiratory support strengthen the segment's relevance. Innovations focused on user comfort, simplified operation, connectivity, and personalized treatment further support adoption and sustained management of sleep-disordered breathing.

The home care settings segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home care settings segment is predicted to witness the highest growth rate. Growing demand for convenient and flexible treatment options is encouraging patients to receive respiratory therapy outside traditional healthcare facilities. Portable CPAP and BiPAP systems, connected technologies, remote monitoring capabilities, and simpler device designs are supporting this transition. Increasing use of telehealth and virtual patient management is also enhancing home-based care. Together, these developments are expanding accessibility, improving treatment continuity, and accelerating adoption of respiratory therapy devices.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share because of strong disease awareness, developed sleep-care infrastructure, and broad access to respiratory treatment technologies. CPAP, BiPAP, and other positive airway pressure solutions are widely used for managing sleep apnea across the region. Increasing diagnosis and sophisticated healthcare services reinforce demand. The United States remains a major contributor, supported by its substantial sleep apnea burden, established clinical capabilities, and mature healthcare ecosystem.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Greater recognition of sleep-disordered breathing, developing medical infrastructure, improved diagnostic services, and broader access to respiratory treatment are driving expansion. Increasing healthcare spending and the region's substantial patient base provide favorable conditions for device adoption. Rising use of homecare therapy, telehealth solutions, and advanced respiratory technologies is further contributing to demand. Continued healthcare investment across developing countries is creating additional opportunities for regional market growth.

Key players in the market

Some of the key players in Sleep Apnea & Respiratory Therapy Devices Market include ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, Drive DeVilbiss Healthcare, Lowenstein Medical SE & Co. KG, BMC Medical Co., Ltd., Inspire Medical Systems, Inc., Compumedics Limited, SomnoMed Ltd., Nihon Kohden Corporation, Natus Medical Incorporated, Breas Medical AB, SEFAM, React Health, Wellell Inc., ZOLL Medical Corporation, Medtronic plc and Cadwell Industries Inc.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In October 2025, Philips Healthcare and Getinge have formed a new commercial partnership in Europe to offer customers easier access to a complete anesthesia and monitoring solution. By combining Philips' monitoring solutions with Getinge's leading anesthesia care products, the partnership provides a single point of contact for purchasing and support, helping clinicians deliver high-quality care in the operating room.

In May 2025, Resmed announced that it acquired VirtuOx, a leading independent diagnostic testing facility (IDTF). VirtuOx provides diagnostic services for sleep, respiratory and cardiac conditions. San Diego-based Resmed, a leader in sleep apnea therapy and digital offerings, says the acquisition reflects its commitment to making care more accessible, more coordinated and more patient-friendly.

Device Types Covered:

  • Positive Airway Pressure (PAP) Devices
  • Oxygen Therapy Devices
  • Ventilators
  • Nebulizers
  • Humidifiers
  • Accessories & Consumables

Applications Covered:

  • Sleep Apnea Management
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Other Respiratory Disorders

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Clinics
  • Home Care Settings

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Sleep Apnea & Respiratory Therapy Devices Market, By Device Type

  • 5.1 Positive Airway Pressure (PAP) Devices
    • 5.1.1 CPAP Devices
    • 5.1.2 BiPAP Devices
    • 5.1.3 APAP Devices
  • 5.2 Oxygen Therapy Devices
    • 5.2.2 Oxygen Concentrators
    • 5.2.3 Oxygen Cylinders
  • 5.3 Ventilators
  • 5.4 Nebulizers
  • 5.5 Humidifiers
  • 5.6 Accessories & Consumables
    • 5.6.1 Masks
    • 5.6.2 Tubing
    • 5.6.3 Filters

6 Global Sleep Apnea & Respiratory Therapy Devices Market, By Application

  • 6.1 Sleep Apnea Management
  • 6.2 Chronic Obstructive Pulmonary Disease (COPD)
  • 6.3 Asthma
  • 6.4 Other Respiratory Disorders

7 Global Sleep Apnea & Respiratory Therapy Devices Market, By End User

  • 7.1 Hospitals
  • 7.2 Ambulatory Surgical Centers (ASCs)
  • 7.3 Clinics
  • 7.4 Home Care Settings

8 Global Sleep Apnea & Respiratory Therapy Devices Market, By Geography

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 United Kingdom
    • 8.2.2 Germany
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Spain
    • 8.2.6 Netherlands
    • 8.2.7 Belgium
    • 8.2.8 Sweden
    • 8.2.9 Switzerland
    • 8.2.10 Poland
    • 8.2.11 Rest of Europe
  • 8.3 Asia Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 South Korea
    • 8.3.5 Australia
    • 8.3.6 Indonesia
    • 8.3.7 Thailand
    • 8.3.8 Malaysia
    • 8.3.9 Singapore
    • 8.3.10 Vietnam
    • 8.3.11 Rest of Asia Pacific
  • 8.4 South America
    • 8.4.1 Brazil
    • 8.4.2 Argentina
    • 8.4.3 Colombia
    • 8.4.4 Chile
    • 8.4.5 Peru
    • 8.4.6 Rest of South America
  • 8.5 Rest of the World (RoW)
    • 8.5.1 Middle East
      • 8.5.1.1 Saudi Arabia
      • 8.5.1.2 United Arab Emirates
      • 8.5.1.3 Qatar
      • 8.5.1.4 Israel
      • 8.5.1.5 Rest of Middle East
    • 8.5.2 Africa
      • 8.5.2.1 South Africa
      • 8.5.2.2 Egypt
      • 8.5.2.3 Morocco
      • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

  • 9.1 Industry Value Network and Supply Chain Assessment
  • 9.2 White-Space and Opportunity Mapping
  • 9.3 Product Evolution and Market Life Cycle Analysis
  • 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

  • 10.1 Mergers and Acquisitions
  • 10.2 Partnerships, Alliances, and Joint Ventures
  • 10.3 New Product Launches and Certifications
  • 10.4 Capacity Expansion and Investments
  • 10.5 Other Strategic Initiatives

11 Company Profiles

  • 11.1 ResMed Inc.
  • 11.2 Koninklijke Philips N.V.
  • 11.3 Fisher & Paykel Healthcare Limited
  • 11.4 Drive DeVilbiss Healthcare
  • 11.5 Lowenstein Medical SE & Co. KG
  • 11.6 BMC Medical Co., Ltd.
  • 11.7 Inspire Medical Systems, Inc.
  • 11.8 Compumedics Limited
  • 11.9 SomnoMed Ltd.
  • 11.10 Nihon Kohden Corporation
  • 11.11 Natus Medical Incorporated
  • 11.12 Breas Medical AB
  • 11.13 SEFAM
  • 11.14 React Health
  • 11.15 Wellell Inc.
  • 11.16 ZOLL Medical Corporation
  • 11.17 Medtronic plc
  • 11.18 Cadwell Industries Inc.

List of Tables

  • Table 1 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 3 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Positive Airway Pressure (PAP) Devices (2023-2034) ($MN)
  • Table 4 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By CPAP Devices (2023-2034) ($MN)
  • Table 5 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By BiPAP Devices (2023-2034) ($MN)
  • Table 6 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By APAP Devices (2023-2034) ($MN)
  • Table 7 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Oxygen Therapy Devices (2023-2034) ($MN)
  • Table 8 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Oxygen Concentrators (2023-2034) ($MN)
  • Table 9 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Oxygen Cylinders (2023-2034) ($MN)
  • Table 10 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Ventilators (2023-2034) ($MN)
  • Table 11 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Nebulizers (2023-2034) ($MN)
  • Table 12 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Humidifiers (2023-2034) ($MN)
  • Table 13 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Accessories & Consumables (2023-2034) ($MN)
  • Table 14 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Masks (2023-2034) ($MN)
  • Table 15 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Tubing (2023-2034) ($MN)
  • Table 16 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Filters (2023-2034) ($MN)
  • Table 17 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 18 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Sleep Apnea Management (2023-2034) ($MN)
  • Table 19 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2023-2034) ($MN)
  • Table 20 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Asthma (2023-2034) ($MN)
  • Table 21 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Other Respiratory Disorders (2023-2034) ($MN)
  • Table 22 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 23 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 24 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Ambulatory Surgical Centers (ASCs) (2023-2034) ($MN)
  • Table 25 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 26 Global Sleep Apnea & Respiratory Therapy Devices Market Outlook, By Home Care Settings (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.